The Australian Clinical Trials Ecosystem and The Challenges Oncoshot Aims to Address

Here is access to the full video of CEO Huren Sivaraj's Health Industry Hub interview with Rozalina Sarkezians where he discusses the critical priorities in the Australian clinical trial ecosystem and the current challenges Oncoshot is aiming to address.

Our partnership with Omico, the Australian Genomic Medicine Centre, is a potential reference model when it comes to secure and timely data sharing for clinical trials between private and public healthcare stakeholders. He also elaborates on his vision for cancer patients over the coming years, that patients should be able to see the standard available therapies and the clinical trial options that are equally relevant to them.

"I envisioned that as an oncologist on a day-to-day basis, for every patient sitting in front of me, I will be able to pull out not just the medical records, but the landscape and visibility of clinical trial options (available to that patient) - not just limited to my domain of knowledge, expertise or awareness at that point of what's happening in my centre, but in a holistic manner."